Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORAZEPAM vs LOSARTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LORAZEPAM vs LOSARTAN: Safety Overview

Metric LORAZEPAM LOSARTAN
Total FAERS Reports 33,404 21,916
Deaths Reported 6,187 2,034
Death Rate 18.5% 9.3%
Hospitalizations 15,431 7,032
Average Patient Age 49.8 yrs 65.2 yrs
% Female Patients 60.8% 59.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 14, 1995
Manufacturer Hikma Pharmaceuticals USA Inc. Aphena Pharma Solutions - Tennessee, LLC
Route INTRAMUSCULAR ORAL
Marketing Status Prescription Prescription